Navigation Links
Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Aug. 1, 2012 /PRNewswire/ -- The laboratory industry rode a roller coaster in 2011, with the economic recovery and the residual dollars of the 2009 American Recovery and Reinvestment Act (ARRA) funding. By the fourth quarter (Q4) of 2011, the market began to soften with hiring freezes and deterioration of most purchasing budgets.

New analysis from Frost & Sullivan's ( Investment Confidence Among Laboratory Decision Makers research finds that in 2012, laboratory decision makers expect their funding conditions to either remain the same or improve marginally. They believe they will have adequate funds to maintain a proper work environment and acquire the necessary technology to achieve their research objectives.

If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

The participants' modestly optimistic outlook is rooted in the responses of 35 percent of laboratory decision makers who believe that business conditions during Q4 2012 will be better than those in Q4 2011. This is a small yet noteworthy increase over the 31 percent who believed that business conditions in Q4 2011 were better than they were during Q4 2010.

"While 42 percent believe that from Q4 2010 through Q4 2012, there will be no change to business conditions, those who believe conditions will be worse decreased from 21 percent to 15 percent," said Frost & Sullivan Research Analyst Karolina Olszewska. "Laboratory decision makers certainly do not expect 2012 to be a vast improvement over 2011; however, they do expect some changes for the better."

The biggest budget cuts from 2010 to 2011 were in furniture, construction and hiring, and budgets for infrastructure and staff are expected to face similar drops in 2012. The ARRA funding was channeled toward the development of multiple new laboratories; therefore, further investments in construction and infrastructure in 2012 will be unlikely. Even research budgets did not change substantially from 2010 to 2011.

The most significant mean budget hikes were in the areas of commodities, supplies and consumables, while the steepest mean budget reduction was for additional and replacement staff.

"Although 2008 to 2011 were unstable for the laboratory industry, some may argue the survivors emerged leaner and more committed to progressing R&D," said Olszewska. "Moreover, the economic turmoil served as a learning experience on staying afloat when faced with limited funding.  Given current expectations from 2012, laboratories can certainly put that education to good use."

Investment Confidence Among Laboratory Decision Makers is part of the Life Sciences Growth Partnership Services program, which also includes research in the following markets: Global Laboratory Product Purchasing Trends; Analysis of the U.S. Clinical Laboratory Market; World Process Analytical Instrumentation Markets; Vital Signs – Laboratory Research Tools Market: The Roller Coaster Ride is Over; and Vital Signs – Used Laboratory Equipment: Bringing Hand-Me-Downs to Science. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Investment Confidence Among Laboratory Decision Makers

Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
2. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
3. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
4. TrovaGene Acquires CLIA - Certified Laboratory
5. New laboratory method uses mass spectrometry to rapidly detect staph infections
6. White House S&T advisor the Honorable Dr. John Holdren tours Naval Research Laboratory
7. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
8. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
9. Instrumentation Laboratory Moves To Direct Distribution Of Hemostasis Product Line In North America
10. Uncertainty Surrounding How to Optimize Laboratory Services?
11. Laboratory Equipment Marketplace Receives Fresh Look and Updated Features
Post Your Comments:
(Date:11/25/2015)... 2015 Studies reveal the differences ... and pave the way for more effective treatment for one ...   --> --> ... problems in cats, yet relatively little was understood about the ... have been conducted by researchers from the WALTHAM Centre for ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... IN (PRWEB) , ... November 25, 2015 , ... ... (AMA) and the Organization of Black Aerospace Professionals (OPBAP) has been formalized with ... and other AMA team leaders met with OPBAP leaders Capt. Karl Minter and ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
Breaking Biology Technology:
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):